Azilsartan: Difference between revisions
Jump to navigation
Jump to search
(Blanked the page) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{CMG}} | |||
===''[[Azilsartan Kamedoxomil|Azilsartan Kamedoxomil]]''=== | |||
* [[Edarbi]] | |||
===''[[Azilsartan Medoxomil /Chlorthalidone|Azilsartan Medoxomil/Chlorthalidone]]''=== | |||
* [[Edarbyclor]] | |||
==Overview== | |||
Azilsartan is a selective AT1 subtype [[angiotensin]] II receptor antagonist used in treatment of [[hypertension]] to lower blood pressure. Common adverse reactions include [[hypotension]]/[[orthostatic hypotension]]. | |||
==Category== | |||
Angiotensin 2 Receptor Blocker | |||
Revision as of 19:28, 2 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Azilsartan Kamedoxomil
Azilsartan Medoxomil/Chlorthalidone
Overview
Azilsartan is a selective AT1 subtype angiotensin II receptor antagonist used in treatment of hypertension to lower blood pressure. Common adverse reactions include hypotension/orthostatic hypotension.
Category
Angiotensin 2 Receptor Blocker